Laser Vaginal Treatment for GSM

Status Recruiting

Clinical Trial Summary

Genitourinary Syndrome of Menopause (GSM) due to low estrogen levels affects about half of post-menopausal women and may have a dramatic impact on women's quality of life. Women complain of vaginal dryness, itching, discomfort, malodour, painful intercourse and may have urinary urgency, irritation, bladder/urethral pain and recurring bladder infections. First-line therapies include vaginal moisturizers, lubricants and estrogen (either oral or with vaginal cream/tablets). While these therapies are effective, the ongoing costs and the resistance to the indefinite use of vaginal creams/inserts is a challenge to the continued use of these therapies. Recently, an innovative laser therapy has been used to treat women with GSM. A randomized controlled trial (RCT) to study how effective the laser is to treat women with GSM is planned.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04042766
Study type	Interventional
Source	Sunnybrook Health Sciences Centre
Contact	Razia Sultana, MD
Phone	4164806100
Email	razia.sultana@sri.utoronto.ca
Status	Recruiting
Phase	N/A
Start date	August 1, 2019
Completion date	March 1, 2026

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04705883` - Vaginal Prasterone In Vaginal Atrophy In Breast Cancer Survivors	Phase 4
Completed	`NCT02937805` - Effects of a Moisturizing Cream on Vaginal and Vulvar Mucous Membranes	N/A
Terminated	`NCT01753102` - Efficacy and Safety Of Spil's Estradiol Vaginal Tablet	Phase 3
Completed	`NCT05378269` - Study of Intravaginal Tamoxifen in PostMenopausal Women With VVA	Phase 1/Phase 2
Completed	`NCT04147689` - Evaluation of the Efficacy and Safety of Hyaluronic Acid Injection in Labia Majora for Volume Restoration	N/A
Recruiting	`NCT05890092` - Vulvar Disease in Nigeria Observational Study
Not yet recruiting	`NCT06333782` - Evaluation of the Safety and Efficacy of Hyaluronic Acid Injection in Labia Majora Augmentation	N/A
Completed	`NCT02966925` - Autologous Platelet Concentrate Combined to Hyaluronic Acid Obtained With Cellular Matrix® BCT-HA Kit and Vulvovaginal Dryness	N/A
Not yet recruiting	`NCT00453089` - VG101 Phase I/II to Treat Vulvar and Vaginal Atrophy in Post-Menopausal Women	Phase 1/Phase 2